Katia Schlienger

9.8k citations
44 papers · 8.0k · 3 hit papers · h-index 24

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Pancreatic and Hepatic Oncology Research
    • PARP inhibition in cancer therapy

Papers in

    • HIV Research and Treatment 9
    • Immunotherapy and Immune Responses 11
    • Immune Cell Function and Interaction 10
    • T-cell and B-cell Immunology 8

Katia Schlienger

43 papers receiving 7.7k citations

Katia Schlienger's Hit Papers

Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer 2019 · 1.8k citations
1.8k0+8+16Years since publication50010001.5k2.0k2.5k

Peers

Katia Schlienger
Comparison fields: 5 of 104
  • Immunology 3.6k
  • Oncology 4.1k
  • Cancer Research 815
  • Reproductive Medicine 436
  • Virology 234
Replace Riccardo Dolcetti with:
Riccardo Dolcetti Italy
Clive R. Wood United States
Heidi F. Horton United States
Nicholas Coleman United Kingdom
Alexander Steinle Germany
Dallas B. Flies United States
Alfred Christian Feller Germany
Yoshiko Iwai Japan
Marij J.P. Welters Netherlands
Laura Carter United States
Katia Schlienger relative to Riccardo Dolcetti Italy Riccardo Dolcetti's profile →
Citations per field
00.5×1.7×
Riccardo Dolcetti · 1×
Citations per year

Countries citing papers authored by Katia Schlienger

Since Specialization
Citations

This map shows the geographic impact of Katia Schlienger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Schlienger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Schlienger more than expected).

Fields of papers citing papers by Katia Schlienger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Schlienger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Schlienger. The network helps show where Katia Schlienger may publish in the future.

Co-authors

The 25 scholars most cited alongside Katia Schlienger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katia Schlienger Line = papers co-authored together Katia Schlienger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Hit paper breakdown →
20032841
2
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Hit paper breakdown →
20191752
3
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Hit paper breakdown →
2001964
4 2002596
5 2002391
6 2003271
7 2002154
8
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
200383
9 200782
10 200066
11 201057
12 200056
13 201155
14
Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
200354
15 200752
16 200047
17 199945
18 199244
19 200638
20 200437

About Katia Schlienger

Katia Schlienger is a scholar working on Virology, Immunology, Epidemiology, Oncology and Infectious Diseases, having authored 44 papers that have together received 8.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers), HIV Research and Treatment (9 papers), Herpesvirus Infections and Treatments (9 papers), T-cell and B-cell Immunology (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Hepatitis B Virus Studies (5 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Immunology (3.6k citations), Oncology (4.1k citations), Cancer Research (815 citations), Reproductive Medicine (436 citations) and Virology (234 citations). Katia Schlienger has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Stephen C. Rubin, George Coukos, Carl H. June, Dionyssios Katsaros, Jose Ramon Conejo-Garcia, Heidi J. Gray, Antonis Makrigiannakis, Phyllis A. Gimotty, Giorgia Regnani and Marco Massobrio. Their work appears in journals such as Annals of Oncology, Vaccine, The Journal of Immunology, Clinical Immunology and Clinical and Vaccine Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact